Searchable abstracts of presentations at key conferences in endocrinology

ea0047oc50 | Innovative Theranostics | Theranostics2016

Radiolabel results from high specific activity e-LINAC produced 67Cu

Stoner Jon L , Gardner Tim J , Smith Suzanne , Jeffery Charmaine , Harris Matt

We developed an improved process for producing high quality 67Cu using an electron accelerator instead of a high energy proton accelerator. The beta/gamma emitting radioisotope 67Cu was created using the (g,p) reaction on isotopically enriched 68Zn target (nominally 40 g, 98% enrichment). The high energy photons were produced by bremsstrahlung conversion of electrons from a 45 MeV electron LINAC. A specially designed water cooled converter, end...

ea0072p13 | (1) | UKINETS2020

Well-differentiated Gastroenteropancreatic G3 NET: Findings from a large single centre cohort

Lithgow Kirstie , Venkataraman Hema , Hughes Simon , Shah Husnain , Kemp-Blake Joanne , Vickrage Suzanne , Smith Stacey , Humphries Sian , Elshafie Mona , Taniere Philipe , Diaz-Cano Salvador , Dasari Bobby , Almond Max , Ford Sam , Ayuk John , Shetty Shishir , Shah Tahir , Geh Ian

Purpose: Neuroendocrine neoplasms are known to have heterogeneous biological behavior. G3 neuroendocrine tumours (NET G3) are characterized by well-differentiated morphology and Ki67>20%. The prognosis of this disease is understood to be intermediate between NET G2 and neuroendocrine carcinoma (NEC). Clinical management of NET G3 is challenging due to limited data to inform treatment strategies.Methods: We describe clinical characteristics, treatment, an...